We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Recommends Pfizer and BMS’ Eliquis to Treat Dangerous Blood Clots
NICE Recommends Pfizer and BMS’ Eliquis to Treat Dangerous Blood Clots
Bristol-Myers Squibb and Pfizer’s Eliquis won a positive nod in the UK, with the National Institute for Health and Care Excellence deeming it clinically effective and cost-effective in treating and preventing blood clots in the lungs, pelvis, legs or arms.